Eupraxia Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.
/ 
Others were interested in
Frequently asked questions
To buy Eupraxia Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Eupraxia Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Eupraxia Pharmaceuticals Inc. is EPRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Eupraxia Pharmaceuticals Inc. has its primary listing on NASDAQ (Small cap). You can trade Eupraxia Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Eupraxia Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Eupraxia Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Eupraxia Pharmaceuticals Inc..